120 related articles for article (PubMed ID: 15139517)
1. Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.
Gittens SA; Kitov PI; Matyas JR; Löbenberg R; Uludağ H
Pharm Res; 2004 Apr; 21(4):608-16. PubMed ID: 15139517
[TBL] [Abstract][Full Text] [Related]
2. Imparting mineral affinity to fetuin by bisphosphonate conjugation: a comparison of three bisphosphonate conjugation schemes.
Gittens SA; Bansal G; Kucharski C; Borden M; Uludag H
Mol Pharm; 2005; 2(5):392-406. PubMed ID: 16196492
[TBL] [Abstract][Full Text] [Related]
3. Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.
Gittens SA; Matyas JR; Zernicke RF; Uludağ H
Pharm Res; 2003 Jul; 20(7):978-87. PubMed ID: 12880282
[TBL] [Abstract][Full Text] [Related]
4. A comparison of mineral affinity of bisphosphonate-protein conjugates constructed with disulfide and thioether linkages.
Wright JE; Gittens SA; Bansal G; Kitov PI; Sindrey D; Kucharski C; Uludağ H
Biomaterials; 2006 Feb; 27(5):769-84. PubMed ID: 16055182
[TBL] [Abstract][Full Text] [Related]
5. Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.
Gittens SA; Bagnall K; Matyas JR; Löbenberg R; Uludag H
J Control Release; 2004 Aug; 98(2):255-68. PubMed ID: 15262417
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of disulfide-linked fetuin-bisphosphonate conjugates with three physiological thiols.
Zhang S; Wright JE; Bansal G; Cho P; Uludag H
Biomacromolecules; 2005; 6(5):2800-8. PubMed ID: 16153121
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate conjugation to proteins as a means to impart bone affinity.
Uludag H; Kousinioris N; Gao T; Kantoci D
Biotechnol Prog; 2000; 16(2):258-67. PubMed ID: 10753453
[TBL] [Abstract][Full Text] [Related]
8. Targeting systemically administered proteins to bone by bisphosphonate conjugation.
Uludag H; Yang J
Biotechnol Prog; 2002; 18(3):604-11. PubMed ID: 12052079
[TBL] [Abstract][Full Text] [Related]
9. Bone affinity of a bisphosphonate-conjugated protein in vivo.
Uludag H; Gao T; Wohl GR; Kantoci D; Zernicke RF
Biotechnol Prog; 2000; 16(6):1115-8. PubMed ID: 11101342
[TBL] [Abstract][Full Text] [Related]
10. A di(bisphosphonic acid) for protein coupling and targeting to bone.
Bansal G; Gittens SA; Uludağ H
J Pharm Sci; 2004 Nov; 93(11):2788-99. PubMed ID: 15368528
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery to bone and mineral deposits using bisphosphonate ligands.
Cole LE; Vargo-Gogola T; Roeder RK
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):12-27. PubMed ID: 26482186
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat.
Price PA; Williamson MK; Nguyen TM; Than TN
J Biol Chem; 2004 Jan; 279(3):1594-600. PubMed ID: 14578360
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex.
Price PA; Lim JE
J Biol Chem; 2003 Jun; 278(24):22144-52. PubMed ID: 12676929
[TBL] [Abstract][Full Text] [Related]
14. Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment.
Price PA; Caputo JM; Williamson MK
J Bone Miner Res; 2002 Jul; 17(7):1171-9. PubMed ID: 12096831
[TBL] [Abstract][Full Text] [Related]
15. A shielding topology stabilizes the early stage protein-mineral complexes of fetuin-A and calcium phosphate: a time-resolved small-angle X-ray study.
Rochette CN; Rosenfeldt S; Heiss A; Narayanan T; Ballauff M; Jahnen-Dechent W
Chembiochem; 2009 Mar; 10(4):735-40. PubMed ID: 19222044
[TBL] [Abstract][Full Text] [Related]
16. Imparting mineral affinity to proteins with thiol-labile disulfide linkages.
Bansal G; Wright JE; Zhang S; Zernicke RF; Uludag H
J Biomed Mater Res A; 2005 Sep; 74(4):618-28. PubMed ID: 16037953
[TBL] [Abstract][Full Text] [Related]
17. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite.
Zhang S; Wright JE; Ozber N; Uludağ H
Macromol Biosci; 2007 May; 7(5):656-70. PubMed ID: 17457941
[TBL] [Abstract][Full Text] [Related]
18. Binding kinetics of a fluorescently labeled bisphosphonate as a tool for dynamic monitoring of bone mineral deposition in vivo.
Tower RJ; Campbell GM; Müller M; Will O; Glüer CC; Tiwari S
J Bone Miner Res; 2014 Sep; 29(9):1993-2003. PubMed ID: 24644087
[TBL] [Abstract][Full Text] [Related]
19. Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on Fetuin-A controlled calcification inhibition.
Heiss A; Pipich V; Jahnen-Dechent W; Schwahn D
Biophys J; 2010 Dec; 99(12):3986-95. PubMed ID: 21156141
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution and pharmacological potential of SM-16896, a novel oestrogen-bisphosphonate hybrid compound.
Tsushima N; Yabuki M; Harada H; Katsumata T; Kanamaru H; Nakatsuka I; Yamamoto M; Nakatsuka M
J Pharm Pharmacol; 2000 Jan; 52(1):27-37. PubMed ID: 10716600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
